SCHEMBL26247268

SCHEMBL26247268

O=C(O)c1c(C2CC2)nn2cccnc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ APOBEC3A P31941 2/20 0.41
▸ APOBEC3G Q9HC16 1/20 0.41
▸ KCNQ3 O43525 4/20 0.40
▸ KCNQ2 O43526 4/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ HPGD P15428 2/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ ALDH1A1 P00352 3/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ JAK2 O60674 3/20 0.35
▸ JAK3 P52333 3/20 0.35
▸ TSHR P16473 1/20 0.35
▸ PIK3CG P48736 2/20 0.35
▸ PIK3CD O00329 1/20 0.35
▸ PIK3R2 O00459 1/20 0.35
▸ IRAK4 Q9NWZ3 1/20 0.35
▸ PPARG P37231 1/20 0.35
▸ RORC P51449 1/20 0.35
▸ HSD11B1 P28845 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23216990 0.79 HPGD (0.40) KCNQ3KCNQ2L3MBTL1HPGDSMN1; SMN2
SCHEMBL25261273 0.77 KCNQ3 (0.43) APOBEC3AAPOBEC3GKCNQ3KCNQ2L3MBTL1
SCHEMBL16619547 0.75 PIK3CG (0.45) APOBEC3AAPOBEC3GJAK2JAK3PIK3CG
SCHEMBL3714513 0.75 PIK3CG (0.51) APOBEC3AAPOBEC3GL3MBTL1HPGDSMN1; SMN2
SCHEMBL23728529 0.75 APOBEC3A (0.45) APOBEC3AAPOBEC3GKCNQ3KCNQ2L3MBTL1
SCHEMBL30028953 0.75 KCNQ3 (0.38) KCNQ3KCNQ2L3MBTL1IRAK4PPARG
SCHEMBL29079557 0.75 KCNQ3 (0.34) APOBEC3AAPOBEC3GKCNQ3KCNQ2L3MBTL1
SCHEMBL29939215 0.74 CYP11B2 (0.37) APOBEC3AAPOBEC3GKCNQ3KCNQ2JAK2
SCHEMBL18208430 0.74 PIK3CG (0.44) APOBEC3AAPOBEC3GJAK2JAK3PIK3CG
SCHEMBL26172231 0.73 HTR6 (0.53) APOBEC3AAPOBEC3GKCNQ3KCNQ2L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230270751-A1 BENZODIAZEPINE DERIVATIVES USEFUL IN TREATING A RESPIRATORY SYNCYTIAL VIRUS INFECTION PFIZER INC. 2023-08-31 — — US disclosed
US-20230270751-A1 BENZODIAZEPINE DERIVATIVES USEFUL IN TREATING A RESPIRATORY SYNCYTIAL VIRUS INFECTION PFIZER INC. 2023-08-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230270751-A1 BENZODIAZEPINE DERIVATIVES USEFUL IN TREATING A RESPIRATORY SYNCYTIAL VIRUS INFECTION CNR1, CNR2, SIGMAR1 APOBEC3A 4339/4885APOBEC3G 4510/4885KCNQ3 617/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback